AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor

Author:

Ren Feng1,Ding Xiao1,Zheng Min1,Korzinkin Mikhail2,Cai Xin1,Zhu Wei1,Mantsyzov Alexey2,Aliper Alex2,Aladinskiy Vladimir2,Cao Zhongying1,Kong Shanshan1,Long Xi2,Man Liu Bonnie Hei2,Liu Yingtao1,Naumov Vladimir2,Shneyderman Anastasia2ORCID,Ozerov Ivan V.2,Wang Ju1,Pun Frank W.2,Polykovskiy Daniil A.2,Sun Chong3,Levitt Michael4,Aspuru-Guzik Alán3,Zhavoronkov Alex12ORCID

Affiliation:

1. Insilico Medicine Shanghai Ltd, Suite 901, Tower C, Changtai Plaza, 2889 Jinke Road. Pudong New District, Shanghai 201203, China

2. Insilico Medicine Kong Kong Ltd, Unit 310, 3/F, Building 8W, Phase 2, Hong Kong Science Park, Pak Shek Kok, Hong Kong, China

3. Department of Chemistry, Department of Computer Science, University of Toronto, Vector Institute for Artificial Intelligence, Canadian Institute for Advanced Research, Toronto, Ontario, Canada

4. Department of Structural Biology, Stanford University, Palo Alto, CA, USA

Abstract

A novel CDK20 small molecule inhibitor discovered by artificial intelligence based on an AlphaFold-predicted structure demonstrates the first application of AlphaFold in hit identification for efficient drug discovery.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemistry

Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3